Form 4: Kenvue CEO Kirk Perry Granted 491,662 Restricted Stock Units

Kenvue Inc.'s CEO, Kirk Perry, was granted 491,662 Restricted Stock Units, vesting over three years.

Summary

• Kirk Perry, Chief Executive Officer of Kenvue Inc. (KVUE), was granted 491,662 Restricted Stock Units (RSUs).
• Each RSU corresponds one-for-one with the Company's common stock.
• The award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029.
• Vesting is contingent upon Mr. Perry's continued service to Kenvue through each respective vesting date.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive commitment and aligns the CEO's interests with long-term shareholder value through equity incentives.

Positives

• The grant of 491,662 Restricted Stock Units to the CEO aligns his interests with long-term shareholder value.
• The multi-year vesting schedule encourages executive retention and sustained performance over the next three years.

Risks

• Vesting of the Restricted Stock Units is subject to the CEO's continued service, meaning the shares are not guaranteed if he departs before the specified vesting dates.

Future Outlook

The grant of long-term equity incentives to the CEO suggests a commitment to his continued leadership and strategic direction for Kenvue over the next three years, aligning executive performance with future company growth and shareholder value creation.

Industry Context

StockSavvy.ai notes that granting Restricted Stock Units (RSUs) is a common practice in the consumer health industry and broader corporate landscape for executive compensation. This method ties executive incentives directly to the company's stock performance and long-term value creation, similar to practices seen at peers like Procter & Gamble or Johnson & Johnson (Kenvue's former parent).

Comparison to Industry Standards

• The grant of 491,662 RSUs to a CEO of a company like Kenvue is consistent with executive compensation packages in large-cap consumer goods and healthcare sectors, where equity forms a significant portion of total compensation.
• The three-year vesting schedule is a standard practice designed to promote long-term retention and align executive interests with shareholder value, comparable to similar grants at companies such as Unilever or Colgate-Palmolive.

Stakeholder Impact

• Shareholders: The grant aligns the CEO's financial interests with the company's long-term stock performance, potentially benefiting shareholders through sustained value creation.
• Employees: The CEO's continued commitment, incentivized by this grant, may contribute to stable leadership and strategic direction for the company.

Next Steps

• Continued service of Kirk Perry through the vesting dates of March 2, 2027, March 2, 2028, and March 2, 2029, for the Restricted Stock Units to fully vest.

Key Dates

Recommendation

This Form 4 reports a routine equity grant to the CEO as part of his compensation package, which is a standard practice to align executive incentives with long-term shareholder value. It does not present new information that would fundamentally alter the investment thesis for Kenvue, thus a 'hold' recommendation remains appropriate based solely on this filing.

Keywords

Kenvue, KVUE, Kirk Perry, Restricted Stock Units, RSU, Insider Transaction, CEO Compensation, Equity Grant, Executive Compensation, Form 4